Right on guys... Thats why I do agree with PA's previous suggestion for a decent capital raising, when the time come to sort out the funding once an for all...
Just wait until good test results for VIR-201 are out in June... The market will then re-rate Virax based on this potential... VHL will sure reach the 30c+ levels...
By then all the big boys will circle Virax for partnership, taking VIR-201 to phase 3 trial and the final FDA approval...
Should Virax wish to have a full control of VIR-201 development then.. We can have some similar deal as Transgene does for this TG4010... I am sure we will have no problem in raising up to $50M through book building auction or placement of shares at premium to instos... Cheers
VHL Price at posting:
11.5¢ Sentiment: None Disclosure: Held